Organo Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Organo de 8.4% y 7.6% por año respectivamente. Se prevé que el BPA crezca en un 8.4% al año. Se espera que la rentabilidad financiera sea de 15.3% en 3 años.

Información clave

10.6%

Tasa de crecimiento de los beneficios

10.5%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Machinery	9.6%
Tasa de crecimiento de los ingresos	6.6%
Rentabilidad financiera futura	15.5%
Cobertura de analistas	Low
Última actualización	13 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

TSE:6368 - Estimaciones futuras de los analistas y datos financieros pasados (JPY Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	179,400	22,500	N/A	N/A	1
3/31/2026	168,733	18,233	13,693	N/A	3
3/31/2025	157,300	17,250	13,630	N/A	2
3/31/2024	150,000	16,098	7,453	N/A	3
12/31/2023	143,535	14,428	N/A	N/A	N/A
9/30/2023	135,778	12,241	-9,143	-7,649	N/A
6/30/2023	134,203	11,832	N/A	N/A	N/A
3/31/2023	132,426	11,730	-19,988	-18,536	N/A
12/31/2022	129,362	11,465	N/A	N/A	N/A
9/30/2022	124,185	11,541	901	3,374	N/A
6/30/2022	117,597	9,887	N/A	N/A	N/A
3/31/2022	112,069	9,210	7,989	10,787	N/A
12/31/2021	109,736	8,787	N/A	N/A	N/A
9/30/2021	105,317	7,690	-3,668	-1,963	N/A
6/30/2021	103,360	7,950	N/A	N/A	N/A
3/31/2021	100,638	7,074	-5,836	-4,582	N/A
12/31/2020	97,899	5,595	N/A	N/A	N/A
9/30/2020	95,162	5,602	2,401	3,415	N/A
6/30/2020	95,951	6,297	N/A	N/A	N/A
3/31/2020	96,515	7,162	7,585	8,553	N/A
12/31/2019	98,097	7,880	N/A	N/A	N/A
9/30/2019	100,166	7,176	2,815	3,753	N/A
6/30/2019	95,496	5,467	N/A	N/A	N/A
3/31/2019	92,273	4,452	5,028	5,646	N/A
12/31/2018	90,629	4,181	N/A	N/A	N/A
9/30/2018	86,005	3,949	3,245	4,017	N/A
6/30/2018	82,697	3,377	N/A	N/A	N/A
3/31/2018	79,226	2,780	-522	624	N/A
12/31/2017	80,154	2,598	N/A	N/A	N/A
9/30/2017	78,753	2,389	N/A	3,887	N/A
6/30/2017	79,333	2,211	N/A	N/A	N/A
3/31/2017	81,114	2,731	N/A	6,610	N/A
12/31/2016	79,574	2,876	N/A	N/A	N/A
9/30/2016	79,604	2,852	N/A	-3,040	N/A
6/30/2016	79,326	2,801	N/A	N/A	N/A
3/31/2016	78,719	2,485	N/A	-4,779	N/A
12/31/2015	75,872	1,648	N/A	N/A	N/A
9/30/2015	73,587	1,390	N/A	375	N/A
6/30/2015	72,169	1,777	N/A	N/A	N/A
3/31/2015	68,741	1,085	N/A	-2,548	N/A
12/31/2014	65,108	633	N/A	N/A	N/A
9/30/2014	63,938	215	N/A	-1,878	N/A
6/30/2014	61,141	-269	N/A	N/A	N/A
3/31/2014	62,096	664	N/A	7,619	N/A
12/31/2013	63,242	1,030	N/A	N/A	N/A
9/30/2013	63,943	1,796	N/A	6,172	N/A
6/30/2013	66,490	2,315	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (8.4% al año) de 6368 es superior a la tasa de ahorro (0.2%).

Beneficios vs. Mercado: Se prevé que los beneficios (10.6% al año) de 6368 crezcan más rápidamente que el mercado JP (9.2% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de 6368 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (7.6% al año) de 6368 crezcan más rápidamente que los del mercado JP (4.4% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 7.6% al año) de 6368 crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 6368 sea baja dentro de 3 años (15.3%).

Organo Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 20% to JP¥8,000

Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Price target increased by 11% to JP¥4,100

Price target increased by 8.6% to JP¥3,800

Price target increased to JP¥3,500

Organo Corporation Revises Consolidated Earnings Guidance for the Six Months Ended September 30, 2022 and for the Fiscal Year Ending March 31, 2023

Recent updates

Is Organo (TSE:6368) A Risky Investment?

Returns On Capital Are Showing Encouraging Signs At Organo (TSE:6368)

Price target increased by 20% to JP¥8,000

Organo's (TSE:6368) Dividend Will Be ¥41.00

Organo Corporation to Report Fiscal Year 2024 Results on May 13, 2024

Upcoming dividend of JP¥41.00 per share

What Does Organo Corporation's (TSE:6368) Share Price Indicate?

Organo Corporation's (TSE:6368) 28% Share Price Surge Not Quite Adding Up

Organo (TSE:6368) Is Due To Pay A Dividend Of ¥41.00

Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Organo Corporation to Report Q3, 2024 Results on Feb 02, 2024

Organo Corporation Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 4, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Organo Corporation Revises Dividend Forecasts for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2024

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Organo Corporation to Report Q2, 2024 Results on Nov 01, 2023

Upcoming dividend of JP¥33.00 per share at 1.7% yield

New minor risk - Share price stability

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Organo Corporation to Report Q1, 2024 Results on Aug 01, 2023

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 11% to JP¥4,100

Organo Corporation, Annual General Meeting, Jun 29, 2023

Upcoming dividend of JP¥29.00 per share at 1.7% yield

Organo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Price target increased by 8.6% to JP¥3,800

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Organo Corporation to Report Q3, 2023 Results on Feb 01, 2023

Price target increased to JP¥3,500

Less than half of directors are independent

Organo Corporation Announces Dividend for the Second Quarter Ended September 30, 2022, Payable on December 5, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023

Second quarter 2023 earnings: Revenues in line with analyst expectations

Organo Corporation Revises Consolidated Earnings Guidance for the Six Months Ended September 30, 2022 and for the Fiscal Year Ending March 31, 2023

Consensus revenue estimates increase by 13%

Investor sentiment improved over the past week

Organo Corporation to Report Q2, 2023 Results on Oct 31, 2022

Upcoming dividend of JP¥80.00 per share

Organo Corporation Provides Dividend Guidance for the Second Quarter Ending September 30, 2022

First quarter 2023 earnings released: EPS: JP¥131 (vs JP¥71.27 in 1Q 2022)

Organo Corporation to Report Q1, 2023 Results on Aug 01, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Organo Corporation Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2023

Organo Corporation, Annual General Meeting, Jun 29, 2022

Price target increased to JP¥10,200

Less than half of directors are independent

Organo Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥72.00 per share

Investor sentiment improved over the past week

Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings released: EPS JP¥163 (vs JP¥186 in 2Q 2021)

Upcoming dividend of JP¥57.00 per share

Investor sentiment improved over the past week

Organo Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2021 and Fiscal Year Ending March 31, 2022

First quarter 2022 earnings released: EPS JP¥71.27 (vs JP¥5.06 loss in 1Q 2021)

Full year 2021 earnings released: EPS JP¥59,453 (vs JP¥626 in FY 2020)

Upcoming dividend of JP¥52.00 per share

Third quarter 2021 earnings released: EPS JP¥131 (vs JP¥132 in 3Q 2020)

Revenue and earnings beat expectations

New 90-day high: JP¥7,140

New 90-day high: JP¥6,320

Organo Corporation to Report Q3, 2021 Results on Feb 01, 2021

New 90-day high: JP¥5,980

Organo Corporation to Report Q2, 2021 Results on Oct 29, 2020

Organo Corporation to Report Q1, 2021 Results on Jul 30, 2020

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas